WallStreetZenWallStreetZen

NASDAQ: SYRS
Syros Pharmaceuticals Inc Earnings & Revenue

Open Broker Account

SYRS past revenue growth

How has SYRS's revenue growth performed historically?
Company
9.59%
Industry
118.61%
Market
185.33%
SYRS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SYRS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SYRS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SYRS earnings and revenue history

Current Revenue
$23.4M
Current Earnings
-$113.7M
Current Profit Margin
-485.1%

SYRS Return on Equity

Current Company
-147.6%
Current Industry
-9.8%
Current Market
-8.3%
SYRS's Return on Equity (-147.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SYRS announces earnings.

SYRS Return on Assets

Current Company
-61%
Current Industry
0.7%
SYRS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SYRS Return on Capital Employed

Current Company
-44.54%
Current Industry
11.5%
SYRS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SYRS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SYRS$23.44M-$106.73M-$113.69M+75.24%N/A
DARE$10.00M-$24.52M-$24.55MN/AN/A
FREQ$0.00-$80.68M-$85.72M-100.00%N/A
ARMP$5.45M-$31.73M-$32.65M+115.57%N/A
CLNN$438.00k-$20.58M-$24.44M+57.31%N/A

Syros Pharmaceuticals Earnings & Revenue FAQ

What were SYRS's earnings last quarter?

On Invalid Date, Syros Pharmaceuticals (NASDAQ: SYRS) reported Q3 2022 earnings per share (EPS) of -$3.21, up 22.46% year over year. Total Syros Pharmaceuticals earnings for the quarter were -$30.25 million. In the same quarter last year, Syros Pharmaceuticals's earnings per share (EPS) was -$4.14.

If you're new to stock investing, here's how to buy Syros Pharmaceuticals stock.

What was SYRS's earnings growth in the past year?

As of Q4 2022, Syros Pharmaceuticals's earnings has grown year over year. Syros Pharmaceuticals's earnings in the past year totalled -$113.69 million.

What was SYRS's revenue last quarter?

On Invalid Date, Syros Pharmaceuticals (NASDAQ: SYRS) reported Q3 2022 revenue of $3.89 million up 31.7% year over year. In the same quarter last year, Syros Pharmaceuticals's revenue was $5.70 million.

What was SYRS's revenue growth in the past year?

As of Q4 2022, Syros Pharmaceuticals's revenue has grown 9.59% year over year. This is 109.02 percentage points lower than the US Biotechnology industry revenue growth rate of 118.61%. Syros Pharmaceuticals's revenue in the past year totalled $23.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.